nanohydroxyapetite

Small moleculeexperimental

Clinical trial activity

5 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
1

Earliest trial started Dec 17, 2014 (NCT03399279)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • nanohydroxyapatite
  • nanohydroxyapetite

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04156152N/AApr 10, 2020Universidad del Desarrollo
NCT02936830Phase 4Oct 1, 2016Riyadh Colleges of Dentistry and Pharmacy
NCT02810548Early Phase 1 (Phase 1)Aug 1, 2016King Abdul-Aziz University
NCT02918617Phase 2May 1, 2015Sangi Co., Ltd., University of Texas, San Antonio
NCT03399279N/ADec 17, 2014Ain Shams University
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Ain Shams UniversityAcademic/Hospital1112014
King Abdul-Aziz UniversityAcademic/Hospital1112016
Riyadh Colleges of Dentistry and PharmacyAcademic/Hospital1112016
Sangi Co., Ltd.For profit1012015
Universidad del DesarrolloAcademic/Hospital1112020
University of Texas, San AntonioAcademic/Hospital1112015
6 organizations
Page 1 / 1